---
title: "SPRBD.US (SPRBD.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/SPRBD.US/news.md"
symbol: "SPRBD.US"
name: "SPRBD.US"
parent: "https://longbridge.com/zh-CN/quote/SPRBD.US.md"
datetime: "2026-03-14T17:02:52.959Z"
locales:
  - [en](https://longbridge.com/en/quote/SPRBD.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SPRBD.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SPRBD.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/SPRBD.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/SPRBD.US/news.md)


# SPRBD.US (SPRBD.US) — 相关新闻

### [](https://longbridge.com/zh-CN/news/277062671.md)
*2026-02-26T15:03:32.000Z*
> XSPRAY Pharmaceuticals: Resubmitting the FDA application for Dacisnock

### [19:02 ET
			
			
				Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration](https://longbridge.com/zh-CN/news/272919362.md)
*2026-01-19T00:05:26.000Z*
> Harbour BioMed has acquired common stock in Spruce Biosciences, increasing its stake to approximately 3.8% of total outs

### [HBM Holdings Acquires 3.8% Stake in Spruce Biosciences](https://longbridge.com/zh-CN/news/272919153.md)
*2026-01-19T00:01:43.000Z*
### [BUZZ-Oppenheimer starts Spruce Biosciences with "outperform" rating on rare disease strength](https://longbridge.com/zh-CN/news/270618668.md)
*2025-12-23T13:12:16.000Z*
### [Spruce Biosciences Sets New Director Compensation Terms with Stock Options and Retainers](https://longbridge.com/zh-CN/news/269722822.md)
*2025-12-15T13:06:02.000Z*
### [Spruce Biosciences Appoints Keli Walbert to Board of Directors](https://longbridge.com/zh-CN/news/269721991.md)
*2025-12-15T13:01:16.000Z*
### [Spruce Biosciences Announces Board Resignation and Stock Repricing](https://longbridge.com/zh-CN/news/269570080.md)
*2025-12-12T21:40:45.000Z*
> Spruce Biosciences announced the resignation of Tiba Aynechi, Ph.D. from its board and a stock option repricing to $104.